B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+0.15%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.03B
AUM Growth
+$3.03B
(+1.6%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-0.36%
Top 10 Holdings %
Top 10 Hldgs %
36.47%
Holding
102
New
13
Increased
18
Reduced
21
Closed
19
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$77.6M |
| 2 |
Harrow
HROW
|
$30.7M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$28.8M |
| 4 |
Day One Biopharmaceuticals
DAWN
|
$25.6M |
| 5 |
Terns Pharmaceuticals
TERN
|
$23.6M |
Top Sells
| 1 |
Natera
NTRA
|
$35.5M |
| 2 |
Travere Therapeutics
TVTX
|
$30.6M |
| 3 |
QuidelOrtho
QDEL
|
$25.7M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$23.8M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$23.3M |
Sector Composition
| 1 | Healthcare | 54.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Adaptive Biotechnologies
ADPT
$2.01B
| $5.73M | 0.19% | +648,451 | New | +$5.73M |
|
52
ALX Oncology
ALXO
$62.7M
| $5.65M | 0.19% | 1,249,900 +991,620 | +384% | +$4.48M |
|
|
SILK
53
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.48M | 0.08% | 63,331 -353,486 | -85% | -$13.8M |
|
54
Immatics
IMTX
$619M
| $2.22M | 0.07% | 322,287 -927,765 | -74% | -$6.4M |
|
55
Esperion Therapeutics
ESPR
$448M
| $1.93M | 0.06% | 1,211,519 -2,181,886 | -64% | -$3.47M |
|
56
Replimune Group
REPL
$422M
| $1.3M | 0.04% | 73,665 -588,684 | -89% | -$10.4M |
|
57
Avalo Therapeutics
AVTX
$122M
| $433K | 0.01% | +247,254 | New | +$433K |
|
58
Kodiak Sciences
KOD
$478M
| – | – | -914,209 | Closed | -$6.55M |
|
59
Milestone Pharmaceuticals
MIST
$156M
| – | – | -1,164,849 | Closed | -$4.61M |
|
60
MoonLake Immunotherapeutics
MLTX
$3.54B
| – | – | -381,120 | Closed | -$4M |
|
61
Nektar Therapeutics
NKTR
$568M
| – | – | -620,280 | Closed | -$1.4M |
|
62
Nkarta
NKTX
$151M
| – | – | -1,525,800 | Closed | -$9.14M |
|
63
Protagonist Therapeutics
PTGX
$3.67B
| – | – | -927,800 | Closed | -$10.1M |
|
|
64
QuidelOrtho
QDEL
$1.95B
| – | – | -300,437 | Closed | -$25.7M |
|
65
RAPT Therapeutics
RAPT
$188M
| – | – | -1,000,000 | Closed | -$19.8M |
|
66
Sarepta Therapeutics
SRPT
$1.78B
| – | – | -140,352 | Closed | -$18.2M |
|
|
67
Travere Therapeutics
TVTX
$1.56B
| – | – | -1,455,585 | Closed | -$30.6M |
|
68
Viridian Therapeutics
VRDN
$1.5B
| – | – | -313,403 | Closed | -$9.15M |
|
|
FUSN
69
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| – | – | -2,000,000 | Closed | -$6.3M |
|
|
IMGN
70
DELISTED
Immunogen Inc
IMGN
| – | – | -3,474,497 | Closed | -$17.2M |
|
|
71
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | -1,493,121 | Closed | -$23.8M |
|
|
ALLK
72
DELISTED
Allakos
ALLK
| – | – | -920,304 | Closed | -$7.75M |
|
73
Apellis Pharmaceuticals
APLS
$3.48B
| – | – | -389,596 | Closed | -$20.1M |
|
74
Cooper Companies
COO
$13.4B
| – | – | -52,115 | Closed | -$17.2M |
|
75
Edwards Lifesciences
EW
$47.8B
| – | – | -235,319 | Closed | -$17.6M |
|